Tag: Allergies: Food
Allergy-Related Psychological Distress Common
Findings seen among adults and children with food allergies, as well as caregivers of children with food allergies
Peanut Consumption Starting in Infancy Provides Lasting Tolerance
Participants in peanut consumption group had lower levels of Ara h2-specific immunoglobulin E, associated with anaphylaxis, at 144 months
Recommendations Developed to Prepare Patients for Oral Immunotherapy
76 statements specific to OIT preparatory procedures were included, as well as 71 on the consent information form
AAAAI: Omalizumab Superior to Placebo for Those With Multiple Food Allergies
16 weeks of omalizumab superior for increasing reaction threshold for peanut and other food allergens
Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen
ACAAI: Parents, Patients Offer Theories on Causes/Origins of Food Allergies
Parents and adult patients with food allergy believe diet, genetics, family history, infection are linked to food allergy development
Sublingual Immunotherapy Safe, Effective for Treating Toddlers’ Peanut Allergy
Improved outcomes seen with younger age at initiation
Gut Microbiome May Predict Later Peanut Allergies
Infants who eventually developed peanut allergies had lower gut microbiome diversity during their early years
Peanut Oral Immunotherapy Effective for Children Under 12 Months
OIT can safely induce desensitization to peanuts in children younger than 12 months of age
Even Transient Food Allergy in Infancy Impacts Later Lung Function
For allergies at age 1 year, lung function deficits and asthma seen at 6 years
